Clinical Trial

Lipid Infusions to Optimize Nutrition Trial

Study acronym: LION
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE or SOLE is more effective in minimizing pulmonary outcomes, neonatal morbidities, long-term morbidity and mortality, and improving discharge growth and Bayley Scales of Infant Development Fourth Edition (BSID-IV) neurodevelopmental assessment at two years
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-06
Trial Details
NCT Number NCT06915441
Lead Sponsor The University of Texas Health Science Center, Houston
Conditions Bronchopulmonary Dysplasia, Neurodevelopmental Impairment
Enrollment 230 participants
Start Date 2026-04-29
Primary Completion 2028-07-30 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-06